CureVac BV - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH

Ticker Exchange SIC # Website Latest Ticker
CVAC Nasdaq 8731 https://www.curevac.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for CureVac BV

CureVac Announces Proposed Public Offering of Common Shares - Feb 7th, 2023 7:20 am
CureVac Welcomes Myriam Mendila as New Chief Development Officer - Feb 1st, 2023 12:15 pm
CureVac Named as One of the World’s Most Dynamic Innovators by LexisNexis(R) - Jan 31st, 2023 2:35 pm
CureVac Shares Pop After Encouraging Update From COVID-19, Flu mRNA Vaccine Programs - Jan 30th, 2023 3:17 pm
CureVac Announces Positive Data in Older Adults from COVID-19 and Flu mRNA Vaccine Development Programs - Jan 30th, 2023 1:30 pm
Omicron subvariant gains more ground in U.S. to account for 49.1% of new COVID cases, CDC data show - Jan 20th, 2023 3:24 pm
CureVac Can Finally Compete With Moderna. It’s an ‘Under-the-Radar mRNA Story.’ - Jan 19th, 2023 8:21 pm
UBS: CureVac has a ‘potentially competitive mRNA platform’ - Jan 19th, 2023 6:56 pm
7 Biotech Stocks That Will Make You Rich in 10 Years - Jan 18th, 2023 8:44 pm
The Petri Dish: Moderna looks at new price tag for Covid vaccine - Jan 12th, 2023 10:39 am
BioNTech seeks to have CureVac patent nullified in German court - Jan 11th, 2023 5:16 pm
Why CureVac's Shares Jumped on Tuesday - Jan 10th, 2023 9:16 pm
CureVac Stock Has Nearly Doubled in 3 Days - Jan 10th, 2023 7:21 pm
Moderna, CureVac and Ocugen offer updates on COVID vaccines, while China cracks down on critics of government’s pandemic response - Jan 9th, 2023 3:39 pm
CureVac Appoints Alexander Zehnder as CEO From April 1, 2023 - Jan 9th, 2023 12:15 pm
CureVac shares surge after preliminary data on COVID-19 and flu shots - Jan 9th, 2023 10:21 am
CureVac N.V. (NASDAQ:CVAC) Shares Could Be 46% Below Their Intrinsic Value Estimate - Jan 7th, 2023 12:03 pm
CureVac Announces Positive Data on Joint COVID-19 and Flu mRNA Vaccine Development Programs - Jan 6th, 2023 12:15 pm
CureVac N.V. (NASDAQ:CVAC) Q3 2022 Earnings Call Transcript - Dec 27th, 2022 2:01 pm
CureVac Members of Management Sell Shares to Cover Tax Obligations from Long Term Incentive Program - Dec 14th, 2022 9:25 pm